SCHEMBL4223368

SCHEMBL4223368

CCOC(=O)c1nc(Nc2cccc(O)c2)nc(Nc2ccccc2OC)c1[N+](=O)[O-]

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3A P49840 2/20 0.51
GSK3B P49841 2/20 0.51
NR1I2 O75469 1/20 0.51
AHR P35869 1/20 0.51
CDK5 Q00535 1/20 0.51
CDK5R1 Q15078 1/20 0.51
MAPT P10636 11/20 0.50
TDP1 Q9NUW8 3/20 0.50
IGF1R P08069 1/20 0.50
BLM P54132 2/20 0.46
POLB P06746 2/20 0.46
RAD52 P43351 1/20 0.46
KMT2A Q03164 1/20 0.46
ATM Q13315 1/20 0.46
GAA P10253 1/20 0.46
ALDH1A1 P00352 1/20 0.44
MAPK1 P28482 2/20 0.43
NPSR1 Q6W5P4 2/20 0.43
RECQL P46063 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4224401 0.91 GSK3A (0.52) GSK3AGSK3BNR1I2AHRCDK5
SCHEMBL1751684 0.91 GSK3A (0.51) GSK3AGSK3BNR1I2AHRCDK5
SCHEMBL656365 0.90 POLB (0.51) CDK5CDK5R1MAPTTDP1IGF1R
SCHEMBL1748903 0.86 GSK3A (0.53) GSK3AGSK3BNR1I2AHRCDK5
SCHEMBL1751472 0.84 IGF1R (0.53) GSK3AGSK3BNR1I2AHRCDK5
SCHEMBL28757222 0.82 MAPT (0.52) GSK3AGSK3BCDK5CDK5R1MAPT
SCHEMBL4052739 0.80 IGF1R (0.51) GSK3AGSK3BNR1I2AHRCDK5
SCHEMBL4227109 0.80 IGF1R (0.51) GSK3AGSK3BNR1I2AHRCDK5
SCHEMBL4052746 0.80 IGF1R (0.51) GSK3AGSK3BNR1I2AHRCDK5
SCHEMBL4221102 0.77 CDC25B (0.43) GSK3AGSK3BNR1I2AHRCDK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2078018-A1 HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND USE THEREOF AS PROTEIN KINASE INHIBITORS Signal Pharmaceuticals LLC (US) 2009-07-15 EP disclosed
WO-2008051494-A1 HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND USE THEREOF AS PROTEIN KINASE INHIBITORS SIGNAL PHARMACEUTICALS, LLC (US) 2008-05-02 WO disclosed